Sana Biotechnology Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -16.99%. The profit margin, also known as the revenue ratio or gross profit ratio ...

City Therapeutics broke cover in October with a $135 million Series A and the opportunity for executive chairman John ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.